What is a common complication of ventilator-associated pneumonia (VAP)?

What is a common complication of ventilator-associated pneumonia (VAP)?

• A. Improved patient outcomes
• B. Decreased morbidity
• C. Increased morbidity and prolonged ICU stay
• D. Rapid recovery of lung function

Answer: (C)

Ventilator-associated pneumonia (VAP) is a significant concern in the intensive care unit (ICU) setting, particularly for patients requiring mechanical ventilation for extended periods. One of the primary complications associated with VAP is increased morbidity and prolonged ICU stay. Patients with VAP often experience a higher incidence of complications, such as systemic infection, respiratory failure, and increased need for additional medical interventions, which collectively contribute to a longer hospitalization. The presence of VAP can lead to multiple negative health outcomes, including deterioration of lung function, increased antibiotic resistance, and further risk of sepsis. This not only affects the patient's immediate recovery but can also complicate their overall treatment plan, necessitating more intensive care and resources. In this context, the other options presented are not typically aligned with the realities of VAP. Improved patient outcomes and decreased morbidity do not generally accompany VAP; rather, patients may face a more challenging recovery. Rapid recovery of lung function is also unrealistic since VAP typically delays the healing process instead of enhancing it.

Ventilator-associated pneumonia (VAP) is a significant concern in the intensive care unit (ICU) setting, particularly for patients requiring mechanical ventilation for extended periods. One of the primary complications associated with VAP is increased morbidity and prolonged ICU stay. Patients with VAP often experience a higher incidence of complications, such as systemic infection, respiratory failure, and increased need for additional medical interventions, which collectively contribute to a longer hospitalization.

The presence of VAP can lead to multiple negative health outcomes, including deterioration of lung function, increased antibiotic resistance, and further risk of sepsis. This not only affects the patient's immediate recovery but can also complicate their overall treatment plan, necessitating more intensive care and resources.

In this context, the other options presented are not typically aligned with the realities of VAP. Improved patient outcomes and decreased morbidity do not generally accompany VAP; rather, patients may face a more challenging recovery. Rapid recovery of lung function is also unrealistic since VAP typically delays the healing process instead of enhancing it.